12.13
Schrodinger Inc stock is traded at $12.13, with a volume of 26,148.
It is up +2.81% in the last 24 hours and up +8.94% over the past month.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
See More
Previous Close:
$11.74
Open:
$12.15
24h Volume:
26,148
Relative Volume:
0.02
Market Cap:
$905.62M
Revenue:
$255.87M
Net Income/Loss:
$-103.27M
P/E Ratio:
-8.5973
EPS:
-1.4109
Net Cash Flow:
$12.46M
1W Performance:
-2.27%
1M Performance:
+8.94%
6M Performance:
-42.93%
1Y Performance:
-53.18%
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, BTSG, TEM, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SDGR
Schrodinger Inc
|
12.12 | 914.58M | 255.87M | -103.27M | 12.46M | -1.4109 |
|
VEEV
Veeva Systems Inc
|
157.87 | 25.89B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
47.57 | 9.17B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
TEM
Tempus Ai Inc
|
51.02 | 9.17B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
HQY
Healthequity Inc
|
81.47 | 6.86B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
25.16 | 4.84B | 1.10B | 112.09M | 283.19M | 0.6096 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-30-25 | Initiated | Goldman | Neutral |
| Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-14-25 | Initiated | Barclays | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
Form DEFA14A Schrodinger, Inc. - StreetInsider
Schrödinger (NASDAQ: SDGR) seeks approval for 3M-share equity plan increase - Stock Titan
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Quantisnow
Schrödinger updates 2025 software growth guidance to 8%-13% amid pharma scale-up delays and operational efficiency focus - MSN
Schrodinger downgraded at Citi after clinical program exit - MSN
Why (SDGR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
SDGR (Schrodinger Inc.) Q4 2025 EPS far outpaces consensus estimates, shares climb 2.32 percent.Fast Rising Picks - Xã Thanh Hà
Schrodinger Inc (SDGR) Shares Fall 4.1% -- What GF Score of 69 Tells Investors - GuruFocus
Schrodinger Inc (SDGR) Shares Fall 4.1% -- What GF Score of 69 T - GuruFocus
Schrodinger: AI Threat Is Looming Large (Rating Downgrade) - Seeking Alpha
Schrodinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
SDGR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Schrödinger to Announce First Quarter 2026 Financial Results on May 5 - GuruFocus
Schrödinger’s impressive revenue growth justifies its high P/S ratio, fueling investor optimism and a bullish view on shares. A warning sign remains, signaling some risks persist despite positive outlooks. - Moomoo
Press Release: Schrödinger to Announce First Quarter 2026 Financial Results on May 5 - 富途牛牛
Schrodinger Inc (SDGR) Stock Up 3.6% and Still Undervalued -- GF Score: 71/100 - GuruFocus
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Schrodinger Inc Targets Software Contract Shift to Hosted Cloud Models - HarianBasis.co
What’s Schrodinger Inc (SDGR) Working Out with Anthropic? - Insider Monkey
How The Schrödinger (SDGR) Narrative Is Shifting With Hosted Software And Lower Price Targets - Yahoo Finance
Is Schrodinger (SDGR) stock failing to hold levels (Overhead Buying) 2026-04-18IPO Watch - Cổng thông tin điện tử tỉnh Lào Cai
Schrodinger (SDGR) Grants Stock Units to New Employees - GuruFocus
Schrodinger (NASDAQ:SDGR) CFO Rachit Jain Sells 844 Shares - MarketBeat
Ramy Farid Sells 43,000 Shares of Schrodinger (NASDAQ:SDGR) Stock - MarketBeat
Schrodinger CEO Farid Ramy sells $1m+ in shares By Investing.com - Investing.com Australia
Schrodinger EVP Rachit Jain sells $10,758 in shares By Investing.com - Investing.com India
Schrodinger EVP Rachit Jain sells $10,758 in shares - Investing.com
Schrodinger CEO Farid Ramy sells $1m+ in shares - Investing.com
Schrodinger (NASDAQ: SDGR) CFO sells 844 shares to cover RSU tax - Stock Titan
Rule 144 notice for SDGR (NASDAQ: SDGR) — 844 restricted shares vest, 1,631 sold earlier - Stock Titan
Ramy Farid plans sale of 86,000 SDGR shares (NASDAQ: SDGR) - Stock Titan
Therese Marie Abrams Net Worth (2026) - GuruFocus
Sumitomo Mitsui Trust Group Inc. Purchases 160,198 Shares of Schrodinger, Inc. $SDGR - MarketBeat
Massachusetts Financial Services Co. MA Raises Stock Position in Schrodinger, Inc. $SDGR - MarketBeat
Baillie Gifford & Co. Sells 139,307 Shares of Schrodinger, Inc. $SDGR - MarketBeat
KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $20 - Moomoo
Understanding Momentum Shifts in (SDGR) - Stock Traders Daily
If You Invested $1,000 in Schrodinger, Inc. (SDGR) - Stock Titan
Schrodinger (HAM:43Z) Cash Receipts from Deposits by Banks and Customers - GuruFocus
Schrodinger (HAM:43Z) Other Assets for Banks - GuruFocus
Schrodinger (HAM:43Z) Other Cash Receipts from Operating Ac - GuruFocus
Schrodinger Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Schrodinger (HAM:43Z) Total Expenses - GuruFocus
Schrodinger Inc Stock Historical Valuations | HAM:43Z - GuruFocus
Schrodinger Inc Stock Intrinsic Values - GuruFocus
Schrodinger Inc (HAM:43Z) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Schrodinger Inc (HAM:43Z)Valuation Measures & Financial Statistics - GuruFocus
Schrodinger Inc (HAM:43Z) Stock News, Headlines & Updates - GuruFocus
Schrodinger Inc (HAM:43Z) Valuation: Possible Value Trap, Think Twice - GuruFocus
Schrodinger Inc Stock Warning Signs | HAM:43Z - GuruFocus
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Schrodinger Inc Stock (SDGR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Farid Ramy | President & CEO |
Apr 16 '26 |
Option Exercise |
3.07 |
43,000 |
132,010 |
373,824 |
| Farid Ramy | President & CEO |
Apr 16 '26 |
Sale |
12.33 |
43,000 |
530,233 |
330,824 |
| Farid Ramy | President & CEO |
Apr 17 '26 |
Sale |
12.21 |
43,000 |
524,944 |
330,824 |
| Jain Rachit | EVP & CFO |
Apr 16 '26 |
Sale |
12.75 |
844 |
10,758 |
51,752 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):